Phio Pharmaceuticals Corp...
(PHIO) ✕
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
undefined
undefined%
At close: undefined
1.82
-1.62%
Pre-market Jan 07, 2025, 04:03 AM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
PE Ratio | -0.15 | -0.45 | -0.97 | -1.4 | -0.49 | -0.32 | -1.01 | -0.54 | -2.44 | -3.99 | -1.63 | -0.92 | -0.00 |
PS Ratio | n/a | n/a | n/a | n/a | 206.17 | 16.81 | 835.53 | 253.47 | 733.38 | 494.78 | 85.30 | 122.35 | n/a |
PB Ratio | 0.20 | 0.47 | 0.58 | 0.95 | 0.75 | 0.17 | 6.84 | 0.44 | 2.80 | 12.80 | 6.89 | -2.03 | -0.00 |
P/FCF Ratio | -0.15 | -0.41 | -1.08 | -1.4 | -0.5 | -0.31 | -1.29 | -0.62 | -3.38 | -4.47 | -5.33 | -2.34 | -0.00 |
P/OCF Ratio | -0.15 | -0.42 | -1.08 | -1.4 | -0.5 | -0.31 | -1.32 | -0.62 | -3.41 | -4.53 | -5.39 | -2.34 | -0.00 |
OCF/S Ratio | n/a | n/a | n/a | n/a | -411.67 | -54.49 | -634.27 | -408.42 | -215.21 | -109.27 | -15.82 | -52.19 | n/a |
Debt / Equity Ratio | n/a | 0.01 | 0.01 | 0.03 | 0.02 | n/a | n/a | n/a | n/a | n/a | n/a | -0.00 | -0.85 |
Quick Ratio | 5.71 | 6.90 | 8.06 | 6.91 | 3.88 | 8.69 | 1.69 | 5.16 | 4.84 | 6.74 | 7.10 | 3.21 | 0.75 |
Current Ratio | 5.71 | 6.90 | 8.06 | 6.91 | 3.88 | 8.69 | 1.69 | 5.16 | 4.84 | 6.74 | 7.10 | 3.21 | 0.75 |
Asset Turnover | n/a | n/a | n/a | n/a | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.03 | 0.02 | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -872.88 | -432.5 | n/a |
Return on Equity (ROE) | -1.4 | -1.04 | -0.6 | -0.68 | -1.54 | -0.54 | -6.79 | -0.83 | -1.15 | -3.21 | -4.23 | 2.21 | 17.41 |
Return on Assets (ROA) | -1.16 | -0.88 | -0.52 | -0.56 | -1.1 | -0.48 | -3.04 | -0.67 | -0.92 | -0.96 | -1.4 | -2.3 | -6.03 |
Return on Capital (ROIC) | -1.4 | -1.04 | -0.61 | -0.65 | -1.46 | -0.54 | -7.67 | -0.83 | -1.15 | -1.12 | -1.63 | -3.32 | 155.73 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.01 | 0.12 | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.02 | -0.47 | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | 79.52% | -3.03K% | -35.70K% | -28.40K% | -20.27K% | -7.90K% | -4.32K% | -13.28K% | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | -42.10K% | -5.33K% | -83.01K% | -47.34K% | -30.07K% | -12.39K% | -5.24K% | -13.28K% | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | -42.42K% | -5.33K% | -93.82K% | -47.34K% | -30.07K% | -12.39K% | -5.24K% | -13.28K% | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | -42.80K% | -5.34K% | -93.75K% | -47.45K% | -30.11K% | -12.43K% | -5.25K% | -13.38K% | n/a |
FCF Margin | n/a | n/a | n/a | n/a | -41.51K% | -5.45K% | -64.78K% | -40.86K% | -21.69K% | -11.06K% | -1.60K% | -5.23K% | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | -42.48K% | -5.28K% | -93.35K% | -47.17K% | -29.88K% | -12.31K% | -5.23K% | -13.10K% | n/a |